No Detail Found!

Serum regenerating islet-derived 1 alpha (reg1α) protein levels as biomarker for type 1 & 2 diabetics

Author(s)
Sadaf Saleem Uppal Department of Biochemistry and Molecular Biology, Army Medical College, Rawalpindi & National University of Science and Technology, Islamabad, Pakistan; Postal Address: H. No: C/69, PNS Shifa, Defence Phase 2, Karachi, Pakistan
Abdul Khaliq Naveed Riphah International University, Islamabad, Pakistan
Saeeda Baig Department of Biochemistry, Ziauddin University, Karachi, Pakistan
Hasan Ali Department of Biochemistry, Bahria University Medical and Dental College, Karachi, Pakistan
Abstract
OBJECTIVES: 1) To compare serum levels of regenerating islet-derived 1 alpha (Reg1a) proteins in type 1 diabetics, type 2 diabetics and controls and correlate them with their clinical/biochemical parameters. 2) To compare Reg1a levels in diabetics with and without disease complications. METHODS: In this cross sectional comparative study, ten type 1 diabetics and thirty type 2 diabetics were recruited from Medical Department of PNS Shifa Hospital, Karachi. Twenty controls were selected from among friends and relatives with non diabetic background. Biochemical parameters like Fasting Blood Glucose (FBG), Glycosylated Hemoglobin (HbA1c), Total Cholesterol (TC) and Triglycerides (TG) were measured. Serum levels of Reg1a were analyzed using ELISA. RESULTS: Reg1a protein levels, compared to controls were significantly higher (p <001) in both type 1 and 2 diabetics with increase more discernible in case of type 2. A decrease in the Reg1a levels was observed with increase in the duration of the disease in type 2 diabetes patients. However the levels of the protein remained significantly higher than the controls. Patients with diabetic complications had higher protein levels as compared to diabetics without complications. We observed positive correlation of Reg1a with age at onset of disease in case of type 1 diabetics (p<0.05). Patients with risk factors like high body mass index and smoking had higher protein levels. CONCLUSION: Reg1a proteins in types 1 and 2 diabetes patients can be used as biological marker for detection of ß-cell apoptosis and regeneration independently. It may be used to identify patients with disease complications.
Publication Details
Page(s) 102-108
DOI DOI not available
Published Journal: Khyber Medical University Journal, Volume: 7, Issue: 3, Year: 2015

Request the full text from PASTIC

Keywords
hemoglobin A, Glycosylated (MeSH), Regenerating Islet-Derived 1 alpha Protein (MeSH), Diabetes Mellitus (MeSH), Diabetes complications (MeSH), human (MeSH), Blood HbA1c protein
0

Citations

0

Downloads

34

Views